regulator rule pain drug
food drug regulators decide friday recommend painkillers linked risk heart attack stroke
food drug administration fda advisory panel verdict hearing evidence painkillers inhibitors brand names celebrex vioxx vioxx withdrawn shops merck selling fda approval fda decide benefits patients justify increased risks
putting vioxx shelves boost profits merck easier battles claim injured drug
merck voluntarily stopped vioxx september caused earnings slide merck shares tumbled millions dollars cover litigation alarm bells rung note approve risk heart attack stroke doubled patients drug inhibitors developed drug merck pfizer users fewer stomach painkillers
pfizer selling celebrex bextra investigations suggested harmful heart merck announcement reintroduction vioxx caught surprise merck peter kim withdrew vioxx based knowing alternative therapies changed light reports cardiovascular risk observed approve vioxx unique class drugs marketed kim explained
thursday david graham fda drug safety advisory panel inhibitors calculations senate dr graham vioxx linked deaths facing stem criticism handling vioxx fda tuesday independent body oversee safety drugs regulators ruled thursday patients heart disease stroke inhibitors medicines agency doctors cautious drugs patients risk factors heart disease
